CBDL

CBD Life Sciences Inc.

OTC · Medicinal Chemicals & Botanical Products · Inc. NV · CIK 0001776073
$0.000300 +15.38%
Vol
Exchange OTC·Sector Medicinal Chemicals & Botanical Products·Inc. NV·CIK 0001776073·Prev Close $0.000260

Analyst Ratings

Historical Analyst Actions
DateFirmActionRating
Feb 3, 2021 Cantor Fitzgerald REITERATE Neutral
Jan 29, 2021 Cantor Fitzgerald MAINTAIN Neutral
Sep 9, 2020 Benchmark MAINTAIN Speculative Buy
Aug 13, 2020 Cantor Fitzgerald MAINTAIN Neutral
May 18, 2020 Cantor Fitzgerald MAINTAIN Neutral

No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 2 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Feb 3, 2021 Cantor Fitzgerald REITERATE Neutral
Jan 29, 2021 Cantor Fitzgerald MAINTAIN Neutral
Sep 9, 2020 Benchmark MAINTAIN Speculative Buy
Aug 13, 2020 Cantor Fitzgerald MAINTAIN Neutral
May 18, 2020 Cantor Fitzgerald MAINTAIN Neutral
Dec 19, 2019 Benchmark MAINTAIN Speculative Buy
Nov 8, 2019 Cantor Fitzgerald INITIATE Neutral
Sep 10, 2019 Benchmark INITIATE Speculative Buy

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.